標(biāo)題: Titlebook: Advances in Radiation Oncology in Lung Cancer; Branislav Jeremi? Book 2023Latest edition The Editor(s) (if applicable) and The Author(s), [打印本頁] 作者: 不友善 時(shí)間: 2025-3-21 17:34
書目名稱Advances in Radiation Oncology in Lung Cancer影響因子(影響力)
書目名稱Advances in Radiation Oncology in Lung Cancer影響因子(影響力)學(xué)科排名
書目名稱Advances in Radiation Oncology in Lung Cancer網(wǎng)絡(luò)公開度
書目名稱Advances in Radiation Oncology in Lung Cancer網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Advances in Radiation Oncology in Lung Cancer被引頻次
書目名稱Advances in Radiation Oncology in Lung Cancer被引頻次學(xué)科排名
書目名稱Advances in Radiation Oncology in Lung Cancer年度引用
書目名稱Advances in Radiation Oncology in Lung Cancer年度引用學(xué)科排名
書目名稱Advances in Radiation Oncology in Lung Cancer讀者反饋
書目名稱Advances in Radiation Oncology in Lung Cancer讀者反饋學(xué)科排名
作者: 乞丐 時(shí)間: 2025-3-21 20:39 作者: 完全 時(shí)間: 2025-3-22 03:47
Place and Role of PET/CT in the Diagnosis and Staging of Lung Cancer staging and diagnosis. However, there are a number of limitations. In this chapter we review the role of FDG PET and FDG PET/CT in the diagnosis, staging, and treatment response assessment of lung cancer.作者: Coronation 時(shí)間: 2025-3-22 08:08 作者: 不能和解 時(shí)間: 2025-3-22 11:16
Climaphobia & Vacuum-Packed Citiesr control while minimizing normal tissue irradiation and treatment-related side effects. This chapter will review historic trials and ongoing studies to provide a comprehensive understanding on the evolution of the RT target in small cell lung cancer.作者: Hyperalgesia 時(shí)間: 2025-3-22 16:22 作者: deface 時(shí)間: 2025-3-22 18:14 作者: legacy 時(shí)間: 2025-3-22 23:40 作者: 熟練 時(shí)間: 2025-3-23 01:39 作者: invulnerable 時(shí)間: 2025-3-23 06:48
Hyeongsaeng Park,Michael T. Turvey staging and diagnosis. However, there are a number of limitations. In this chapter we review the role of FDG PET and FDG PET/CT in the diagnosis, staging, and treatment response assessment of lung cancer.作者: Obstreperous 時(shí)間: 2025-3-23 12:02 作者: ARENA 時(shí)間: 2025-3-23 14:37 作者: dragon 時(shí)間: 2025-3-23 20:12
Dynamics of Interpersonal Coordination, and very high spatial resolution. The aim of the current chapter is to review the role of contrast-enhanced MDCT in the diagnosis and staging of lung cancer and characterization of solitary pulmonary nodules.作者: Oration 時(shí)間: 2025-3-23 23:27 作者: 浮夸 時(shí)間: 2025-3-24 05:03 作者: Trabeculoplasty 時(shí)間: 2025-3-24 06:40 作者: diskitis 時(shí)間: 2025-3-24 10:55 作者: Aids209 時(shí)間: 2025-3-24 16:46 作者: Phagocytes 時(shí)間: 2025-3-24 20:59
Organizations in Artificial Social Systemsile has allowed a better understanding of the lung cancer biology and the development of targeted therapies with improved efficacy and toxicity profile compared to standard cytotoxic chemotherapy. Nevertheless, most of the targetable alterations occur in patients with adenocarcinoma histology and vi作者: Defiance 時(shí)間: 2025-3-25 01:00
Towards Sustained Team Effectivenessence. These mechanisms comprise the addition of methyl groups to a cytosine within a CpG dinucleotide, referred to as DNA methylation, posttranslational and covalent modifications of the histone proteins, and chromatin remodeling. The different epigenetic events elicit structural and functional chan作者: Mawkish 時(shí)間: 2025-3-25 05:26 作者: 統(tǒng)治人類 時(shí)間: 2025-3-25 08:08
Dynamical Systems and Internal Modelsmunotherapy in the past two decades along with the rapidly advanced molecular diagnostic testing. As such, accurate subtyping of lung carcinomas has become of paramount importance for appropriate patient management. In addition, a systematic approach to histologic classification of lung adenocarcino作者: 元音 時(shí)間: 2025-3-25 15:21 作者: Insulin 時(shí)間: 2025-3-25 16:44
Hyeongsaeng Park,Michael T. Turveyays the most widely used radiopharmaceutical in oncologic studies is the F18-labeled glucose (FDG). The introduction of integrated PET/CT scanners provides information about both anatomy (CT) and function (PET). The fused images from PET/CT greatly assist image interpretation and offer more accurate作者: 特征 時(shí)間: 2025-3-25 21:53
https://doi.org/10.1007/BFb0036780r we focus on the second task of this dogma, which involves staging. We specifically provide an overview of the current TNM staging classifications for lung cancer, a description of various invasive mediastinal staging modalities, the evidence supporting invasive mediastinal staging procedures, and 作者: 釋放 時(shí)間: 2025-3-26 02:16 作者: 聯(lián)想 時(shí)間: 2025-3-26 07:30
https://doi.org/10.1007/978-3-662-48005-2 radiation, or hypofractionation, declined as evidence mounted that these doses caused considerable damage to normal tissues. Based on radiobiology, treatments then shifted toward smaller daily doses over a period of several weeks as a way to reduce this damage yet still achieve tumor control. A par作者: Decongestant 時(shí)間: 2025-3-26 09:40
A. T. Caselli,C. Liccioli,F. Tassiy cause of disease progression in lung cancer and improved local control has been associated with improved overall survival in both non-small cell (NSCLC) and small cell lung cancers (SCLC) (Arriagada et al. .; Machtay et al. .; Pignon et al. .). Delivery of radiation to the intrathoracic sites of d作者: Addictive 時(shí)間: 2025-3-26 13:00 作者: occult 時(shí)間: 2025-3-26 18:28 作者: 負(fù)擔(dān) 時(shí)間: 2025-3-26 20:58 作者: 有害 時(shí)間: 2025-3-27 02:31 作者: Relinquish 時(shí)間: 2025-3-27 07:05
Climaphobia & Vacuum-Packed Citiesle (hemi-thoracic) “portal” drawn on a chest X-ray film. Six decades of advances in radiologic and nuclear medicine imaging have led to a revision of this classically defined target to one that more accurately reflects the true extent of actual disease. Accuracy in target definition has been matched作者: 無可爭辯 時(shí)間: 2025-3-27 12:14 作者: 兒童 時(shí)間: 2025-3-27 14:03 作者: 吹牛大王 時(shí)間: 2025-3-27 21:24 作者: fluffy 時(shí)間: 2025-3-28 00:01
Advances in Radiation Oncology in Lung Cancer978-3-031-34847-1Series ISSN 0942-5373 Series E-ISSN 2197-4187 作者: amputation 時(shí)間: 2025-3-28 06:01
Branislav Jeremi?Considers in detail all aspects of the radiation oncology of lung cancer.Presents and discusses the role of different treatment strategies and their outcomes and toxicities.Written by leading lung can作者: Spangle 時(shí)間: 2025-3-28 08:50
Medical Radiologyhttp://image.papertrans.cn/a/image/149535.jpg作者: 機(jī)警 時(shí)間: 2025-3-28 10:40
Genomic Alterations in Lung Cancerile has allowed a better understanding of the lung cancer biology and the development of targeted therapies with improved efficacy and toxicity profile compared to standard cytotoxic chemotherapy. Nevertheless, most of the targetable alterations occur in patients with adenocarcinoma histology and vi作者: auxiliary 時(shí)間: 2025-3-28 16:23 作者: prosperity 時(shí)間: 2025-3-28 21:04
Interventional Pulmonology cancer invading central airways (trachea and principal bronchi). While success ratio of interventional techniques is reported to vary in different studies, they remain a vital part of armamentarium with excellent potential and perspective. Increase in number and variety of these techniques led to t作者: 攤位 時(shí)間: 2025-3-28 23:06
Pathology of Lung Cancermunotherapy in the past two decades along with the rapidly advanced molecular diagnostic testing. As such, accurate subtyping of lung carcinomas has become of paramount importance for appropriate patient management. In addition, a systematic approach to histologic classification of lung adenocarcino作者: BACLE 時(shí)間: 2025-3-29 04:54 作者: 受傷 時(shí)間: 2025-3-29 09:39 作者: 山崩 時(shí)間: 2025-3-29 15:13
Surgical Staging of Lung Cancerr we focus on the second task of this dogma, which involves staging. We specifically provide an overview of the current TNM staging classifications for lung cancer, a description of various invasive mediastinal staging modalities, the evidence supporting invasive mediastinal staging procedures, and 作者: 古代 時(shí)間: 2025-3-29 18:28
Surgical Workup and Management of Early-Stage Lung Cancer Results Program 2021a). Overall survival (OS) remains dismal at 21% at 5 years (National Cancer Institute Surveillance, Epidemiology, and End Results Program 2021b). Treatments for lung cancer include multiple modalities, including surgical resection, systemic treatment (chemotherapy or immunothera作者: 休息 時(shí)間: 2025-3-29 22:11 作者: 煩躁的女人 時(shí)間: 2025-3-30 00:26
Radiation Time, Dose, and Fractionation in the Treatment of Lung Cancery cause of disease progression in lung cancer and improved local control has been associated with improved overall survival in both non-small cell (NSCLC) and small cell lung cancers (SCLC) (Arriagada et al. .; Machtay et al. .; Pignon et al. .). Delivery of radiation to the intrathoracic sites of d作者: 逢迎春日 時(shí)間: 2025-3-30 08:01 作者: ARK 時(shí)間: 2025-3-30 08:17 作者: 辯論 時(shí)間: 2025-3-30 15:01
PET and PET/CT in Treatment Planningrticularly for those who are candidates for potentially curative radiation therapy (RT) (Akhurst et al. 2015; De Ruysscher et al. 2010). .F-Fluorodeoxyglucose (.F-FDG) remains the most widely used PET radiopharmaceutical in oncology and FDG-PET has proven to be the most accurate whole-body imaging m作者: precede 時(shí)間: 2025-3-30 19:32 作者: pacifist 時(shí)間: 2025-3-30 23:34 作者: excursion 時(shí)間: 2025-3-31 01:07 作者: FLORA 時(shí)間: 2025-3-31 08:52 作者: fabricate 時(shí)間: 2025-3-31 10:59 作者: 宿醉 時(shí)間: 2025-3-31 14:53
Towards Sustained Team Effectivenessy, thus contributing to cancer development. In this chapter, the different epigenetic processes that are disrupted in cancer cells are described with special focus on the genetic abnormalities that disturb chromatin stability to promote lung cancer development.作者: 裝飾 時(shí)間: 2025-3-31 18:19 作者: 異常 時(shí)間: 2025-3-31 21:48
Dynamical Systems and Internal Modelso therapeutic decision-making will also be described, and a multimodality approach for a comprehensive diagnosis of advanced NSCLC including predictive biomarker testing will be discussed. Finally, given that the scope of this publication is radiation oncology, the chapter will end with a discussion
